Session

Management of liver disease

EFFICACY OF ORAL VANCOMYCIN FOR TREATMENT OF PRURITUS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A RANDOMIZED CONTROLLED CLINICAL TRIAL
EFFICACY OF ORAL VANCOMYCIN FOR TREATMENT OF PRURITUS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A RANDOMIZED CONTROLLED CLINICAL TRIAL

HEPATIC RECOMPENSATION ACCORDING TO BAVENO VII CRITERIA IS LINKED TO A CLEAR SURVIVAL BENEFIT IN PATIENTS WITH DECOMPENSATED ALCOHOL-RELATED CIRRHOSIS
HEPATIC RECOMPENSATION ACCORDING TO BAVENO VII CRITERIA IS LINKED TO A CLEAR SURVIVAL BENEFIT IN PATIENTS WITH DECOMPENSATED ALCOHOL-RELATED CIRRHOSIS

LOW LEVELS OF QHBSAG AND LONG TERM ANTIVIRAL THERAPY ARE ASSOCIATED WITH SUCCESSFUL TREATMENT WITHDRAWAL IN NON-CIRRHOTIC HBEAG-NEGATIVE CHRONIC HEPATITIS B
LOW LEVELS OF QHBSAG AND LONG TERM ANTIVIRAL THERAPY ARE ASSOCIATED WITH SUCCESSFUL TREATMENT WITHDRAWAL IN NON-CIRRHOTIC HBEAG-NEGATIVE CHRONIC HEPATITIS B

MORE THAN JUST AN ITCH: IMPACT OF CHOLESTATIC PRURITUS IN PRIMARY BILIARY CHOLANGITIS ON HEALTH-RELATED QUALITY OF LIFE
MORE THAN JUST AN ITCH: IMPACT OF CHOLESTATIC PRURITUS IN PRIMARY BILIARY CHOLANGITIS ON HEALTH-RELATED QUALITY OF LIFE

MANIPULATION OF A P75NTR-POSITIVE HEPATIC STELLATE CELL SUBPOPULATION PROTECTS MICE FROM ACETAMINOPHEN-INDUCED LIVER INJURY
MANIPULATION OF A P75NTR-POSITIVE HEPATIC STELLATE CELL SUBPOPULATION PROTECTS MICE FROM ACETAMINOPHEN-INDUCED LIVER INJURY

MANIPULATION OF A P75NTR-POSITIVE HEPATIC STELLATE CELL SUBPOPULATION PROTECTS MICE FROM ACETAMINOPHEN-INDUCED LIVER INJURY
MANIPULATION OF A P75NTR-POSITIVE HEPATIC STELLATE CELL SUBPOPULATION PROTECTS MICE FROM ACETAMINOPHEN-INDUCED LIVER INJURY

Management of liver disease  et al.

MORE THAN JUST AN ITCH: IMPACT OF CHOLESTATIC PRURITUS IN PRIMARY BILIARY CHOLANGITIS ON HEALTH-RELATED QUALITY OF LIFE
MORE THAN JUST AN ITCH: IMPACT OF CHOLESTATIC PRURITUS IN PRIMARY BILIARY CHOLANGITIS ON HEALTH-RELATED QUALITY OF LIFE

Management of liver disease  et al.

LOW LEVELS OF QHBSAG AND LONG TERM ANTIVIRAL THERAPY ARE ASSOCIATED WITH SUCCESSFUL TREATMENT WITHDRAWAL IN NON-CIRRHOTIC HBEAG-NEGATIVE CHRONIC HEPATITIS B
LOW LEVELS OF QHBSAG AND LONG TERM ANTIVIRAL THERAPY ARE ASSOCIATED WITH SUCCESSFUL TREATMENT WITHDRAWAL IN NON-CIRRHOTIC HBEAG-NEGATIVE CHRONIC HEPATITIS B

Management of liver disease  et al.

HEPATIC RECOMPENSATION ACCORDING TO BAVENO VII CRITERIA IS LINKED TO A CLEAR SURVIVAL BENEFIT IN PATIENTS WITH DECOMPENSATED ALCOHOL-RELATED CIRRHOSIS
HEPATIC RECOMPENSATION ACCORDING TO BAVENO VII CRITERIA IS LINKED TO A CLEAR SURVIVAL BENEFIT IN PATIENTS WITH DECOMPENSATED ALCOHOL-RELATED CIRRHOSIS

Management of liver disease  et al.

EFFICACY OF ORAL VANCOMYCIN FOR TREATMENT OF PRURITUS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A RANDOMIZED CONTROLLED CLINICAL TRIAL
EFFICACY OF ORAL VANCOMYCIN FOR TREATMENT OF PRURITUS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A RANDOMIZED CONTROLLED CLINICAL TRIAL

Management of liver disease  et al.

Item 1 - 10 / 10
1